Gonzalo Sánchez‐Benavides

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected

Marc Suárez‐Calvet, Thomas K. Karikari, Juan Lantero‐Rodriguez et al. · EMBO Molecular Medicine · 2020 · 414 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Long-term exposure to residential green and blue spaces and anxiety and depression in adults: A cross-sectional study

Mireia Gascón, Gonzalo Sánchez‐Benavides, Payam Dadvand et al. · Environmental Research · 2018 · 379 citations

Public Health, Health Sciences, Urban Health +16

Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease

Marta Milà‐Alomà, Nicholas J. Ashton, Mahnaz Shekari et al. · Nature Medicine · 2022 · 349 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial

Rafael de la Torre, Susana Solá, Gimena Hernández et al. · The Lancet Neurology · 2016 · 286 citations

Medicine, Neurology, Neuroscience +9

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's <i>continuum</i>

Marta Milà‐Alomà, Gemma Salvadó, Juan Domingo Gispert et al. · Alzheimer s & Dementia · 2020 · 263 citations · Full text

Life Sciences, Neurology, Neuroscience +17